TENX Stock — Tenax Therapeutics Inc

Tenax Therapeutics Inc (TENX)

Updated October 16, 2026.

TENX is a Stock. Its deepest 1-year drawdown was 92.6%.

Tenax Therapeutics is a development-stage pharmaceutical company focused on creating novel cardiopulmonary therapies for conditions including pulmonary hypertension and heart failure. The company does not currently distribute to shareholders. This security may appeal to investors seeking exposure to early-stage drug development with high risk and potential reward characteristics.

TENX performance

Returns are updating. TENX's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 92.6%.

TENX key facts

Asset type

Stock

Asset class

Equity

Inception date

07/24/1995

Distribution frequency

None

Last close

$1.36 (as of 2026-10-16)

Market cap

$50,896,527

Average volume

1774605.0

Payment date

02/26/2018

Beta

0.917

Payout ratio

0.0%

Forward P/E

0.299

EPS

$-1.42

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

TENX risks and drawbacks

The deepest 1-year drawdown on record here is 92.6%.

Who may consider TENX — and who may not

It is a weaker fit for investors who need monthly cash flow (TENX does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on TENX

• All tickers starting with T

Tagged: Healthcare.

Frequently asked questions